These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2121490)

  • 1. Left ventricular function as an end-point of thrombolytic therapy.
    Norris RM; White HD
    Eur Heart J; 1990 Aug; 11 Suppl F():5-9. PubMed ID: 2121490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
    White HD; Cross DB; Elliott JM; Norris RM; Yee TW
    Circulation; 1994 Jan; 89(1):61-7. PubMed ID: 8281696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infarct-related artery patency and long-term effects on left ventricular remodelling.
    Visser CA
    Cardiology; 1997; 88 Suppl 1():26-35; discussion 36. PubMed ID: 9118165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of thrombolytic therapy on left ventricular function in patients over with those under 60 years of age.
    White H; Cross D; Scott M; Norris R
    Am J Cardiol; 1991 May; 67(11):913-8. PubMed ID: 1902054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarction.
    Henzlova MJ; Bourge RC; Papapietro SE; Maske LE; Morgan TE; Tauxe EL; Rogers WJ
    Am J Cardiol; 1991 Jun; 67(16):1354-9. PubMed ID: 1904189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
    Cross DB; Ashton NG; Norris RM; White HD
    J Am Coll Cardiol; 1991 Apr; 17(5):1039-46. PubMed ID: 1901072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction.
    White HD
    Chest; 1989 May; 95(5 Suppl):265S-269S. PubMed ID: 2495909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation between streptokinase and r-TPA in limiting the myocardial damage during an acute myocardial infarct. An echocardiographic study].
    Morelloni S; Fasciolo L; Freggiaro V; Corazza M; Pareti G; Davi R; Allegri M
    Clin Ter; 1990 Dec; 135(5):359-65. PubMed ID: 2150366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.
    Norris RM; White HD; Cross DB; Woo KS; Elliott JM; Twigden D; Williams B; Johnson RN
    Br Heart J; 1993 Jun; 69(6):485-91. PubMed ID: 8343313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular function following thrombolytic therapy for myocardial infarction.
    French JK; White HD
    Clin Exp Pharmacol Physiol; 1995 Mar; 22(3):173-9. PubMed ID: 7554409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.